Alzheimer’s Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study
Year: 2015
Type: article
Source: Journal of Alzheimer s Disease
DOI: 10.3233/jad-150247
Authors: Qiao-Xin Li, Victor L. Villemagne, James D. Doecke, Alan Rembach, Shannon Sarros, Shiji Varghese, Amelia McGlade, Katrina M. Laughton, Kelly K. Pertile, Christopher J. Fowler, Rebecca L. Rumble, Brett O. Trounson, Kevin Taddei, Stephanie R. Rainey-Smith, Simon M. Laws, Joanne S. Robertson, Lisbeth A. Evered, Brendan Silbert, Kathryn A. Ellis, Christopher C. Rowe, S. Lance Macaulay, David Darby, Ralph N. Martins, David Ames, Colin L. Masters, Steven Collins
Institutions: The University of Melbourne, Florey Institute of Neuroscience and Mental Health, Austin Hospital, Austin Health, Commonwealth Scientific and Industrial Research Organisation, Australian e-Health Research Centre, Edith Cowan University, Hollywood Private Hospital, St Vincent's Hospital Melbourne, The University of Western Australia, National Ageing Research Institute
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2253163222
